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SUMMARY
The cumulative incidence function is widely reported in competing risks studies, with group
differences assessed by an extension of the log-rank test. However, simple, interpretable
summaries of group differences are not available. An adaptation of the proportional hazards model
to the cumulative incidence function is often employed, but the interpretation of the hazard ratio
may be somewhat awkward, unlike the usual survival set-up. We propose nonparametric
inferences for general summary measures, which may be time-varying, and for time-averaged
versions of the measures. Theoretical justification is provided using counting process techniques.
A real data example illustrates the practical utility of the methods.
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1. INTRODUCTION
The cumulative incidence function quantifies the cause-specific failure probability with
competing risks data, where the dependent censoring from competing causes invalidates the
Kaplan—Meier [1] estimator. Nonparametric analyses of the cumulative incidence function
have been widely adopted [2], particularly in clinical trial settings [3]. Counting process
methods [4] may be used to nonparametrically estimate cause-specific hazard functions [5],
which may then be combined to estimate the cumulative incidence function. The log-rank
test has been extended [6] to evaluate group differences in cumulative incidence, with
alternative testing procedures developed by Pepe [7] and Lin [8].
In two-group survival analyses with independent censoring, the Kaplan—Meier estimators
are reported, along with results from the log-rank test and the hazard ratio estimated under
the proportional hazards model [9]. With competing risks data, the nonparametric estimates
of the cumulative incidence function are reported, frequently complemented by the results of
Gray’s [6] test. While the proportional hazards model has been adapted to the cumulative
incidence function by Fine and Gray [10] and Scheike et al. [11], the interpretation of the
corresponding hazard ratio is somewhat awkward and the analysis is often omitted. The
estimated hazard ratios from the cause-specific hazard functions cannot be used to infer the
magnitude of group differences on the cumulative incidence functions, directly.
Copyright © 2008 John Wiley & Sons, Ltd.
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In Section 2, we propose inferences for alternative summary measures based on
nonparametric estimates of the cumulative incidence functions, which may be time-varying.
This includes absolute difference, risk ratio, and odds ratio, which are more easily
interpreted than the hazard ratio of the subdistribution proposed by Fine and Gray [10].
Theoretical issues are addressed using counting process techniques. The results permit the
construction of confidence bands for time-varying summary measures and confidence
intervals for time-averaged summary measures. The analyses give a fuller understanding of
how group differences change over time than does the Fine and Gray [10] model.
The methodology’s practical utility is illustrated in an analysis of a bone marrow transplant
study in Section 3, where absolute differences and risk ratios are intuitively meaningful in
quantifying covariate effects on the cumulative incidence functions. The case study shows
that the effect of platelet levels on treatment related failure is strongest at early time points
but wanes in the long run, which may be the time horizon of greatest clinical interest.
Some remarks conclude in Section 4.
2. NONPARAMETRIC INFERENCES FOR SUMMARY MEASURES
2.1. Nonparametric estimation of cumulative incidence function
We first review the usual nonparametric estimators for the cumulative incidence functions.
Standard asymptotic results are presented, which are needed when making inference about
the proposed summary measures. Simple plug-in formulas for the estimators and their
associated variance estimators are given in the text, with additional details given in the
Appendix.
For subject j in group i, let Tij and Cij be the event time and censoring time, respectively. Let
Xij=min(Tij, Cij), Δij= (Tij≤Cij), and εij ∈{1, …, K} be the cause of failure. For right-
censored competing risk data, we assume that for the ith treatment group, {Xij, Δij, Δijεij} are
independent and identically distributed for j=1, …, ni, and assume that the observed data are
independent between two treatment groups.
Let
be the cause-specific hazard function of cause 1 in group i=1, 2. The cumulative incidence
function for cause 1 is
where Si(u-)=pr(Tij≥u) is the overall survival probability and  is the
cumulative cause-specific hazard function of cause 1.
To estimate the cumulative incidence function, Fi1(t), let 0=ti0<ti1<⋯<ti D be the distinct
times where event of cause 1 occurred for the ith sample. At time tij, let Yij, rij and dij be the
number of subjects at risk, the number of events of cause 1 occurred and number of events
of other than cause 1 occurred for the ith sample. A nonparametric estimator of Fi1(t), i=1, 2,
is given by
Zhang and Fine Page 2














are the Kaplan—Meier estimator for the overall survival distribution, Si (t), and Nelson—
Aalen [12,13] estimator for the cumulative hazard function, , respectively.
Andersen et al. [4] and Lin [8], among others, have studied the asymptotic properties of .
Under regularity conditions described in the Appendix, for i=1, 2,
uniformly in t ∈[0, τ] for a fixed τ, and  converges weakly in D[0, τ] to a
tight Gaussian process. Moreover, , for all s,t. The joint uniform
asymptotic normality of the nonparametric estimators is important when developing
inferences for summary measures.
For variance estimation, we require a consistent estimator of the influence function ,
say, . The influence function is complicated, so we omit the formulas here. Interested
readers may find explicit expressions for  and  in the Appendix. A consistent
variance estimator for  may be based on the estimated influence
function:
2.2. Summarizing differences in cumulative incidence functions
To summarize differences in cumulative incidence, we consider general functionals
G{(F11(t), F21(t))}, where G(u,v) maps (D[0, τ], D[0, τ]) to  and has absolutely continuous
partial derivatives in u and v, and is bounded at Fi1(t), for t ∈[0, τ] [4]. When G{F11(t),
F21(t)} is constant in t, the cumulative incidence functions satisfy certain transformation
models with time-independent covariate effects [14,15] including the proportional
subdistribution hazards model [10]. We suggest three intuitively meaningful
transformations, G1(u,v)=u - v, G2(u,v)=u/v, for v>0, and G3(u,v)={u/(1-u)}/{v/(1-v)}, for
0<u,v<1. The function G1 is the differences ofthe two cumulative incidence probabilities,
while G2 and G3 may be interpreted as the relative risk and the odds ratio of these
probabilities, respectively, at a time t ∈[0, τ]. These quantities have been widely used for
summarizing differences of probabilities with binary data. In the current setting, where the
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cause-specific failure probabilities change over time, these measures are completely
unspecified, so that the differences may be time-dependent.
To combine information in G{F11(t), F21(t)} across time, we propose weighted average
summaries,
where W(t)>0 is a deterministic weight function, , and [τl, τu]∈[0, τ] is the time
region of interest. If G{F11(t), F21(t)}=β is time-independent, then the weighted average
corresponds to the regression parameter in a transformation model [14,15]. For example,
with G(u,v)=log{-log(1-u)}-log{-log(1-v)}, β is the subdistribution hazard ratio [10].
However, in general,  does not require that such a model holds. The weighted integral 
may be interpreted as an average difference, average relative risk, or average odds ratio for
Gk, k=1, 2, 3, respectively, which may be intuitively meaningful for researchers.
The weighting idea is similar in spirit to that of Fleming and Harrington [16], who proposed
a class of weighted log-rank tests for censored survival data. Mimicking the weighted log-
rank tests, one might consider a class of weights based on the cumulative incidence function
from pooling the two samples. This class of weights is rather flexible, and permits one to
give greater weight either to early or late departures between two cumulative incidence
curves, as well as weighting equally over time. An attractive feature of the uniform weight is
that the summary measure may be interpreted as a simple weighted average.
2.3. Estimation of G{F11(t), F21(t)}
We estimate G{F11(t), F21(t)} by . The following paragraphs provide
details of variance estimation.
The weak convergence of the estimator at a fixed t and a corresponding variance estimator
can be established using functional delta method. Some additional notation and assumptions
are needed to state these results. Let G(1)(u,v)=∂G(u,v)/∂u and G(2)(u,v)=∂G(u,v)/∂v. Define
n=n1 +n2 and assume that ni/n → ρi as n, where 0<ρi<1.
Since  converges weakly to a Gaussian vector
process, the functional delta method gives that 
is uniformly asymptotically equivalent to
where the influence function  can be estimated by 
(see Appendix for detail). Thus,  converges
weakly to a Gaussian process with variance consistently estimated by
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2.4. Confidence intervals and bands for G{F11(t), F21(t)}
For inferences about time-varying group differences, one may construct a (1-α)× 100 per
cent confidence interval for G{F11(t), F21(t)}. The interval endpoints may be calculated as
, where pr(N(0, 1)≥Zα/2)=α/2. For a fixed time t ∈[0, τ],
a pointwise hypothesis test of H0 : F11(t)=F21(t) can be based on the asymptotic normality.
For the difference of two cumulative incidence curves using G1, a (1-α)× 100 per cent
confidence interval for {F11(t)—F21(t)} is
To construct the confidence interval for the relative risk and odds ratio with G2 and G3,
respectively, we suggest an additional transformation, f(G), to force the lower bound of the
confidence interval to be positive and to improve the coverage probability in small samples.
The log- and arcsine-square root transformations are well-known choices for f [17]. For the
log-transformation, the variance of 
can be estimated by . Then, a (1-α)× 100 per cent log-
transformed confidence interval for G{F11(t), F21(t)} can be constructed as
Computing (1-α)× 100 per cent confidence bands for G{F11(t), F21(t)} may be helpful in
identifying those time regions where F11 and F21 are different. It is difficult to construct
such bands analytically, since the estimated functional does not have a simple martingale
structure. We adapt Lin’s [8] resampling technique [18] to generate the confidence bands for
the difference. For a general transformation function G, we construct (1-α)× 100 per cent
confidence bands for G{F11(t), F21(t)} by a simple resampling technique.
Let ; i=1, 2; j=1, …, ni; b=1, …, N be independent standard normal variates. It can be
shown that the simulated process
has the same limiting process as , uniformly for
t ∈[0, τ]. Let Cα be the (1-α) 100th percentile of
for b=1, …, N. Then, (1-α)× 100 per cent confidence bands for G{F11(t), F21(t)} are
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For the relative risk and odds ratio, a log- or arcsine-square root transformation may be used
to construct the bands as well.
2.5. Inference for time-averaged differences
A natural estimator for the time-averaged difference, , is
The functional delta method gives that
where . The Lindeberg—Feller central limit theorem yields that
 converges in distribution to a normal random variable. The asymptotic
variance can be estimated by . To make inference, normal theory (1-α)×
100 per cent confidence intervals may be calculated for .
3. BONE MARROW TRANSPLANT DATA
We illustrate the proposed summary measures on data from the International Bone Marrow
Transplant Registry, consisting of 408 patients treated with HLA-identical sibling bone
marrow transplantation for myelodysplasia and having complete platelet data. Two
competing endpoints are of interest [19]: treatment-related mortality (TRM) [N=161(40 per
cent)], defined as death in remission, and relapse [N=87(21 per cent)]. One hundred and
sixty (39 per cent) patients were censored at end of study. A key issue in patient
management is identifying factors that influence the cumulative incidence of these
outcomes.
Fitting univariate proportional cause-specific hazards models provided risk factors
associated with the cause-specific hazards for TRM and relapse, respectively. These include
pre-transplantation platelet level (>100×109/L[N=128(31 per cent)] versus ≤100 × 109/
L[N=280(69 per cent)]). The estimated cause-specific hazard ratios (95 per cent confidence
intervals) are 0.55 (0.38–0.79) and 0.82 (0.52–1.28) for TRM and relapse, respectively.
These results suggest higher platelet levels are strongly associated with a reduction in TRM
and that there is a smaller, but insignificant, reduction in relapse. While useful, such
analyses do not yield direct information about the magnitude of the platelet effect on the
cumulative incidence of the endpoints.
The estimated subdistribution hazard ratios (95 per cent confidence intervals) 10 and p-
values from Gray’s [6] test are 0.59 (0.41–0.84) 0.003 and 1.03 (0.66–1.61) 0.880 for TRM
and relapse, respectively. The results for TRM are quite similar from the two analyses, in
part because of the relatively weak effect of platelets on the cause-specific hazard of relapse.
Conversely, the platelet effect is weaker on the cumulative incidence of relapse, in part
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because of the relatively strong platelet effect on the cause-specific hazard of TRM.
Intuitively, patients with high platelet levels experience TRM less frequently and hence have
greater cumulative risk of relapse, attenuating the positive effect of high platelet levels on
the cause-specific hazard for relapse.
The proposed methodology is now employed to elucidate the time-varying nature of the
platelet effect. Figures 1 and 2 plot the cumulative incidence curves for TRM and relapse for
the two platelet groups, along with the time-varying difference, relative risk, and odds ratio,
respectively. They also show the 95 per cent confidence intervals and confidence bands
from N=1000 resamples. These figures indicate that platelets have a time-varying effect on
the cumulative incidence of TRM (see Figure 1), but not on relapse (see Figure 2). To
formally test for time-varying effects, we fit the Fine and Gray’s [10] proportional
subdistribution hazards model with a time-dependent covariate. The test gives p-values of
0.05 and 0.92 for TRM and relapse, respectively, suggesting that the proportional
subdistribution hazards model may not be a good fit for the cumulative incidence of TRM.
For TRM, one observes that patients with platelets >100×109/L have a lower cumulative
incidence, but the advantage diminishes over time (Figure 1). The confidence bands
demonstrate that the differences are statistically significant for the first 36 months post-
transplantation, but not at later times. Taking W=1/(τu-τl) in , where (τl, τu)=(0.164,70)
month, the average difference, relative risk, and odds ratio for platelets >100×109/L versus
≤100×109/L are -14 per cent (-24 to -5 per cent; p=0.003), 0.65 (0.48–0.88; p=0.006), and
0.53 (0.34–0.82; p=0.004), respectively, with the p-values being quite similar to that from
Gray’s test. The average summary measures provide important information about the
magnitude of the cumulative incidence differences, and may be more easily interpreted than
the subdistribution hazard ratio [10]. Patients with platelets >100×109/L have a time-
averaged 14 per cent reduction in the incidence of treatment-related death, while the time-
averaged relative risk and odds ratio of treatment-related death are 65 and 53 per cent,
respectively.
For relapse, patients with high or low platelets have almost identical cumulative incidence
curves (Figure 2) that are not significantly different at any time point using the confidence
band procedure. The average difference, relative risk, and odds ratio of relapse for platelets
>100×109/L versus ≤100×109/L are 1 per cent (-7-9 per cent; p=0.853), 1.01 (0.68–1.50;
p=0.974), and 1.02 (0.62–1.70; p=0.931), respectively. The p-values are similar to that from
Gray’s 6 test. These findings are helpful in confirming the earlier analyses, which could
have potentially missed a subtle time-varying effect.
The case study has demonstrated that the proposed time-varying and time-averaged
measures can be usefully applied to compare two cumulative incidence curves and provide
important information about the magnitude of the differences. When goodness-of-fit tests
indicate that time-dependent effects in cumulative incidence functions exist, reporting the
estimated hazard ratio from the Fine and Gray [10] model may be misleading, since the
model assumes that this ratio does not change over time. The definition of the time-averaged
measure accounts explicitly for such time-dependence and permits analyses of quantities
like risk ratio and odds ratio which may be more easily understood by practitioners.
The confidence band methodology was helpful for answering the question: ‘At what times
are the two cumulative incidence curves different?’. This may be particularly important in
clinical applications, both for physicians and patients. For example, in the bone marrow
transplant study, the effect of platelets only manifests in the short run, with long-run
probabilities of treatment-related mortality not appearing to depend as strongly on platelet
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levels. If long-term treatment failure is of ultimate interest, then these long-run probabilities
may be of greater clinical relevance in patient management.
4. REMARKS
In this paper, we proposed a general class of time-dependent summary measures for group
differences in two cumulative incidence functions. For scenarios where the differences may
vary over time, we suggested averaging the measures across time. In the case that the
difference is time-independent, there is a simple relationship between the summary measure
and a transformation model in which there is a single binary covariate coding the group
effect [14]. Estimation methods for such regression models could be used, including [14,15].
However, the proposed estimators in the current paper have a simple closed form as well as
simple plug-in variance estimators, leading to straightforward inferences. The existing
regression methods are more complex computationally, requiring the solution of certain
estimating equations. Moreover, their interpretation may be unclear under time-varying
dependence, unlike our approach, in which the time-averaged summary measure is estimated
explicitly. The ad hoc pseudo-value approach of [15] might also be employed to estimate the
time-dependent summary measures at fixed times. However, the theoretical properties of the
procedure are not fully understood and the construction of the pseudo-values seems
computationally more intensive in light of the current proposal. Additional research is
needed to rigorously explore this method in the present setting.
In the bone marrow transplant example, the effects of the covariates on the cause-specific
hazard and cumulative incidence functions were in the same direction but with somewhat
different magnitudes. As discussed in Section 3, this occurs because the effect of a covariate
on the cumulative incidence of a particular cause is mediated via its direct effect on the
cause-specific hazard of that cause and via its indirect effect on the cause-specific hazards
for other causes. When the effects of a covariate on the cause-specific hazards are in
opposite directions, it may occur that the covariate effect on the cumulative incidence
function of a particular cause is opposite to its effect on the corresponding cause-specific
hazard. In such cases, care is needed in interpreting the results, which requires examining
the effects on all causes simultaneously. The proposed methods are useful in understanding
time-varying differences in the cumulative incidence function, which may help to refine the
evaluation of these covariate effects. Future research is planned to explore the manner in
which covariate effects on the cause-specific hazard functions contribute to time-varying
differences on the cumulative incidence functions.
FORTRAN code implementing the analysis is available from the authors upon request. R
and SAS code is currently under development for future release.
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APPENDIX
Nonparametric estimation of Fi1, i=1, 2, may be based on counting process techniques (see
Andersen et al. [4]). Let Nij(t)= (Xij≤t, Δij=1) and  be the counting process
of all causes of failure and observed counting process of type 1 failure for the jth individual
in ith group, respectively. Denote  and , and define the
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risk set as , where Yij(t)= (Xij≤t). Under regularity conditions, it is well
known that
uniformly in t ∈[0, τ], where  and
 are the martingales corresponding to Nij(t) and ,
respectively, and Λi(t)=-d{log[Si(t)]} is the cumulative hazard function for all causes in
group i, and  (see Pepe [7], p. 772 for details). Thus, it follows that
uniformly in t ∈[0, τ], where
which can be consistently estimated by a plug-in estimator [20],
where , , and
.
Note that  uniformly for t ∈[0, τ] and ni/n→ρi as n→∞, where 0<ρi<1.
Thus, by Taylor expansion,
uniformly in t ∈[0, τ].
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Cumulative incidence function (CIF) of treatment-related mortality (TRM) by platelets
(platelets >100×109/L) versus (platelets ≤100×109/L).
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Cumulative incidence function (CIF) of relapse by platelets (platelets >100×109/L) versus
(platelets ≤100×109/L).
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